gluco-care

What gluco-care does

Gluco-Care is a medical device brand wholly owned by MediVena that develops, markets, and distributes a portfolio of diabetes care products serving consumers living with diabetes, healthcare professionals, and veterinary clinics. The portfolio spans four product clusters: blood collection (personal lancets, lancing devices with 7-depth settings, and Gamma-sterilized single-use safety lancets); glucose monitoring (the GLUCO-CARE® 100 blood glucose meter with 7/14/30-day averaging, reminder alarms, and a 20-600 mg/dL measuring range); insulin delivery (fixed-needle insulin syringes with reduced dead space, standard and "Plus" pen needles using thin-wall/extra-thin-wall technology with electro-polished cannula and medical-grade lubricant, insulin safety syringes, and the ONE-CARE® safety pen needles with visual lock indication); and ancillary safety products (ISO 80369-compatible safety needles, Luer-Lock syringes for testing/vaccination, and the GLUCO-CARE® VET U-40/U-100 veterinary insulin syringes). All products are designed and manufactured under the MediVena umbrella with an emphasis on affordability, sharps safety, and patient comfort rather than connectivity or digital features.

The company's go-to-market is primarily consumer-direct and channel-driven: products are sold through a branded Amazon storefront, the gluco-care.com direct-to-consumer website, and distributor relationships, with regional customer support provided from its US headquarters in Atlanta (1 Glenlake Parkway, Ste 700), its European headquarters in Warsaw, Poland (MediVena Sp. z o.o.), and an operations office in Leiria, Portugal. Revenue mechanics are hardware-based, one-time/recurring consumable sales of branded medical devices, with pricing not publicly disclosed and no subscription or software model apparent. No enterprise customer contracts, framework agreements, or institutional buyers are named in the data.

Gluco-Care was founded in 2020 as a dedicated diabetes-care product brand within MediVena, which is a private company with no disclosed venture capital, private equity investment, funding rounds, M&A activity, or management team biographical data available in the input. The company holds the registered GLUCO-CARE® trademark and operates the differentiated sub-brands ONE-CARE® (safety pen needles) and GLUCO-CARE® VET (animal diabetes), positioning itself as a complete-solution, price-competitive alternative to incumbent diabetes device manufacturers such as Becton Dickinson and Cardinal Health's Monoject.

Name

gluco-care

Legal name

GLUCO-CARE™ by MediVena

Website

https://gluco-care.com

Company type

Private

Founded year

2020

Operating status

Operating

Short description

Gluco-Care is a MediVena-owned medical device brand that develops and markets affordable diabetes care products — glucose monitors, insulin syringes, pen needles, and safety lancets — serving people with diabetes, healthcare professionals, and veterinary clinics via Amazon and direct sales across the US and Europe.

Ownership category

akta.pro rank

Product category

Diabetes Care Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Insulin Pen Needles, Syringes & Infusion Sets (Consumables) (HLAHAHAE)

akta.pro secondary industries

Blood Glucose Monitoring (BGM) Meters & Test Strips (HLAHAHAG), Diabetes Care Device Accessories & Adhesives (Sensors/Pump Supplies) (HLAHAHAL)

Keywords

• Diabetes care devices
• Blood glucose monitoring
• Insulin delivery devices
• Medical syringes and needles
• Safety lancets and lancing devices

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Device Hardware Sales: Sales of diabetes care medical devices including glucose monitors, insulin syringes, pen needles, lancets, and safety needles. Products are sold as one-time purchases through Amazon marketplace, direct website sales, and potentially through distributors.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Core offering

Gluco-Care develops, manufactures, and distributes medical devices for diabetes care under a complete solution spanning blood collection (safety lancets and lancing devices), glucose monitoring (Glucose Monitor 100 meter with strips), and insulin delivery (insulin syringes, pen needles, safety pen needles, and safety needles). The product line is sold through direct e-commerce (gluco-care.com) and the Amazon marketplace, and additionally includes a dedicated GLUCO-CARE VET sub-brand of U-40 and U-100 insulin syringes for animal diabetes management.

Product overview

Gluco-Care is a medical device company offering a complete diabetes care solution through multiple interconnected products. The portfolio centers on blood glucose monitoring (Glucose Monitor 100), insulin delivery (Insulin Syringes, Insulin Safety Syringes, Pen Needles, Pen Needles Plus, Safety Pen Needles), and blood collection (Safety Lancets, Lancing Devices). The company also provides Safety Needles and Syringes for general medical use, and a veterinary line (GLUCO-CARE VET) for animal diabetes management. All products are developed and manufactured by parent company MediVena, focusing on affordability, safety, and patient comfort with features like thin-wall technology, electro-polished needles, and medical-grade lubricants.

Differentiator

Problem solved

Functional benefit

Brands

• ONE-CARE®: Safety Pen Needles product line offering simple handling similar to major brands with compact size and visual indication when needle is permanently locked
• GLUCO-CARE® VET

Products and services

• GLUCO-CARE® Glucose Monitor 100
• GLUCO-CARE® Insulin Syringes Fixed needle insulin syringes for people with diabetes available in 0.3 mL, 0.5 mL, and 1 mL sizes, comparable to Becton Dickinson and Cardinal Monoject syringes. Features precise graduation, reduced dead space to minimize medication loss, and a tri-beveled electro-polished cannula coated with medical grade lubricant for comfort.
• GLUCO-CARE® Insulin Safety Syringes Insulin syringes with integrated safety mechanisms designed to reduce the risk of accidental needlestick injury. Available in models 2131 and 2132. Intended for users who require insulin administration plus sharps-injury protection.
• GLUCO-CARE® Pen Needles Insulin pen needles available in 29G-31G gauge sizes. Feature thin wall and extra-thin wall technology for smoother insulin flow, with precisely grounded, electro-polished, medical-grade-lubricated tips to minimize injection force. Compatible with major insulin pen devices.
• GLUCO-CARE® Pen Needles Plus Enhanced insulin pen needles (models 3022-3028) with thin-wall and extra-thin-wall technology engineered for smooth insulin flow and improved patient comfort during injection.
• ONE-CARE® Safety Pen Needles Safety pen needles designed to be handled like standard pen needles without special training. Feature compact size and a visual indication when the needle is permanently locked after the safety mechanism engages.
• GLUCO-CARE® Safety Lancets Gamma-sterilized, single-use safety lancets (models 1111-1118) with silicone-coated ultra-thin needles, color-coded versions, and a 3-step ergonomic operation designed to prevent sharps injuries. Intended for capillary blood sampling by patients and clinicians.
• GLUCO-CARE® Safety Needles Safety needles with an integrated safety mechanism to reduce risk of accidental needlestick injury. Compatible with all syringes using Luer and Luer Lock connectors per ISO 80369. Intended for clinical and general medical use.
• GLUCO-CARE® Syringes and Needles Luer-Lock 1 mL syringes with hypodermic needles suitable for sample preparation and vaccine injections. Silicone-lubricated barrels with high transparency for clinical and vaccination use.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• MediVenacoreStrategic or Co-development PartnerGluco-Care is a brand owned by MediVena, a medical device company. MediVena develops and brings innovative medical devices for blood testing and drug delivery. Gluco-Care focuses specifically on diabetes care products while MediVena operates globally with offices in the US and Europe.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Becton, Dickinson and Company (BD): Global medical device leader and dominant incumbent in insulin syringes, pen needles, and lancets. Explicitly cited by Gluco-Care as a benchmark competitor in insulin syringes, making it the most direct large-scale peer in the consumables category.
• Cardinal Health: Major medical products distributor and manufacturer of Monoject syringes. Named alongside BD in Gluco-Care's product description as the incumbent benchmark for insulin syringes, directly comparable in product category and customer base.
• Nipro Diagnostics (Nipro True): Global medical device and diagnostics company with a major diabetes monitoring and pen needle business. A broader incumbent whose diabetes products (TRUE brand meters, pen needles, lancets) directly overlap Gluco-Care's portfolio.
• Abbott Diabetes Care (FreeStyle Libre): Division of Abbott operating the market-leading FreeStyle Libre CGM system. A broader incumbent in adjacent diabetes technology whose dominance in continuous glucose monitoring defines the strategic landscape Gluco-Care operates within.
• Dexcom: Pure-play continuous glucose monitoring leader (G6, G7). A broader incumbent whose category leadership in CGM represents the primary technology shift affecting traditional BGM and consumables suppliers like Gluco-Care.

Direct peers

• Owen Mumford: Specialist manufacturer of safety lancets, pen needles, and injection devices for diabetes and diagnostics. Highly comparable niche competitor focused on diabetes injection and blood collection consumables, competing in the same channels and customer segments as Gluco-Care.
• HTL-STREFA: Manufacturer of safety lancets, pen needles, and capillary blood sampling devices. A focused diabetes and sharps-safety competitor with a comparable product portfolio (especially in lancets and pen needles) and similar mid-market positioning.
• Trividia Health: US-based diabetes care company offering TRUE METRIX blood glucose meters and test strips. A directly comparable niche BGM and consumables player targeting similar cost-conscious consumers and competing in the same retail channels.
• ARKRAY: Japan-based manufacturer of blood glucose monitoring systems, test strips, and lancets. A comparable BGM-focused peer with global distribution and overlapping product categories to Gluco-Care's monitoring and consumables portfolio.

Emerging players

• Simple Diagnostics: Value-oriented manufacturer of blood glucose meters, test strips, lancets, and alcohol prep pads. A smaller-scale direct competitor targeting the same affordable-diabetes-supplies niche that Gluco-Care addresses through Amazon and DTC channels.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about gluco-care